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ABSTRACT:   
 
We have shown the efficacy of Quantum Dots (qdots), nano-scale fluorescent 
particles made of semi-conductive material, as versatile biologically 
functional research tools.  This functionality depends upon a series of 
chemical transformations that produce stable, aqueous, biomolecule-bound 
qdots with high quantum yield.  We utilize the metal binding and chelating 
properties of the amino acid histidine to displace hydrophobic surface ligands 
and to phase-transfer qdots from organic to aqueous media.  The intermediate 
binding strength of histidine to qdot surface facilitates its exchange with a 
variety of strongly binding thiolated biomolecules.  Ligand profiles are 
subsequently characterized via FTIR, NMR, and gel electrophoresis.  
Negatively-charged aqueous qdots are shown to be taken-up and contained 
within phospholipid liposomes formed via several different protocols.  
Flexible liposome synthetic procedures allow intercalation of a number of 
moieties into liposomal membranes, including hydrophobic dyes and 
hydrophobic qdots.  Possible implications for cellular delivery are discussed.
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Advice to future Honors Students: 
 
 
Associate yourself with a lab, the earlier the better.  Develop a trusting 
relationship with your laboratory advisor (PI).  Enjoy what you're doing; the 
more reflective and free time you put into your research, the better and more 
meaningful it will turn out.  Be prepared to run many more flawed or 
inconclusive experiments than successful ones. 
 
 
Most importantly, concerning completion of your Capstone as a research-
driven scientist, it is extremely helpful to regularly defend and contextualize 
your work.  Not only is this true for presenting your research in poster or 
powerpoint format, but it is true for proposal and application writing as well.  
Do not hesitate to apply for awards, scholarships, fellowships, or research 
programs that require proposals and personal statements, as the experience 
you gain writing them is invaluable. 
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INTRODUCTION 
 Quantum dots (qdots) are nano-scale crystalline particles that consist of 
a semiconductive core material, such as CdSe, and a bound organic ligand 
coating responsible for chemical interactions with their surroundings.  As a 
function of their size and composition, qdots fluoresce tunably across the 
visible region of the electromagnetic spectrum when excited with ultraviolet 
radiation, making it possible to synthesize separate synthetic batches with 
unique emission profiles (2).  Furthermore, like metallic nanoparticles, the 
molecular ligand profile at the qdot surface can be chemically manipulated so 
as to dramatically alter their interactive properties (3).  The molecular 
properties afforded by ligand bound to qdot determine both solvent and target 
compatibility of particles.   
 This aspect is of critical importance for bioimaging and biosensing 
interests, which demand a range of specific chemical targeting properties (4).  
Various peptides, proteins, polymers, molecular probes, and oligonucleotide 
sequences have been experimentally attached to qdots to afford novel 
biological recognition (5, 6).  Importantly, functionally disparate moieties can 
be attached to afford synergistic properties, a particle characteristic termed 
multimodality (7).  An initial problem concerning biomolecule attachment is 
that qdots synthesized by high temperature annealing utilize trioctylphosphine 
oxide (TOPO) and/or oleylamine (OAm) as coordinating ligands and present 
hydrophobic moieties at their surface.  Thus, synthesized particles are soluble 
within nonpolar solvents (2); biological systems are largely aqueous and 
initially incompatible with these particles (see 1-qdot, Figure 1). 
 Various techniques have been investigated for the phase transfer of 
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nanocrystals for their utilization within aqueous biological environments.  
These techniques can be divided into two broad categories: those involving 
the formation of a molecular surface bilayer, and those involving molecular 
monolayer exchange.  A popular method of bilayer-mediated phase transfer 
involves "wrapping" hydrophobic particles with polymer consisting of 
alternating hydrophobic and hydrophilic moieties, such as poly(maleic 
anhydride alt-1-tetradecene) (8).  Similarly, due to their amphipathicity and 
biocompatibility, phospholipids can be used to form bilayers on 1-qdot 
surfaces and provide water solubility (9).  Advantages of bilayer-mediated 
qdot phase transfer include low loss of quantum yield, since the fluorescent 
core of these qdots is not directly altered, as well as straightforward and often 
facile binding protocols (10). However, particles containing an organic 
molecular surface bilayer often have increased hydrodynamic diameter (Dh), 
as well as chemical limitations concerning further biomolecule 
functionalization compared to direct attachment (11). 
 A second category of nanoparticle phase transfer involves an altogether 
exchange of surface monolayer.  Protocols involve chemically exchanging the 
bound hydrophobic ligands with ones that present a hydrophilic moiety to the 
solvent, often short-chain mercapto acids (12, 13) or other thiolated ligands, 
such as polyethylene glycol (PEG) (14).  The amino acid L-cysteine has been 
shown to function as an efficient mediator of phase transfer, displacing TOPO 
from qdot surfaces (15).  However, the sulfur-cadmium or sulfur-zinc bond is 
strong and relatively permanent.  Our goal has been to achieve quick, facile, 
and efficient phase transfer of particles while facilitating their further direct 
surface modification with a tunable array of other stabilizing or functional 
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molecules.  For this purpose, we have been utilizing a method of qdot phase 
transfer involving the amino acid L-histidine.  We have shown that it can 
quickly and efficiently exchange with TOPO and OAm and induce phase 
transfer with acceptable loss of quantum yield.  Furthermore, L-histidine 
maintains only an intermediate binding strength to the semiconductive surface 
(1), allowing for its replacement with other more strongly binding moieties.  
Part 1 of this experimental report deals this L-histidine-mediated phase 
transfer protocol and its subsequent role in providing means for further 
functionalization of qdots (see Figure 1). 
  Bioimaging and biosensing with qdots is critically dependent upon their 
cellular uptake (3).  Qdots do not readily diffuse cellular membranes and so 
must be either taken up actively by cells via endocytosis, or enter through 
compromise of the cellular membrane.  It has been shown that various cell 
lines tend to slowly endocytize negatively charged particles based on 
electrostatic interactions (6, 16).  Faster, more efficient endocytosis-driven 
uptake can be achieved by targeting endocytosis mediated cell surface 
receptors with molecular agonists attached to particle surfaces (5, 17, 18, 19).   
 Cell-mediated uptake, however, very often results in permanent particle 
localization within endosomes and/or lysosomes (14, 18, 20), which normally 
serve to process nutrients.  Methods by which nanoparticles have been shown 
to escape endosomes include their attachment to adenoviral vectors (21) as 
well as their functionalization with acid-sensitive endosome-disrupting 
moieties (22).  Other delivery methods involve deliberate compromise of 
cellular membranes in order to actively deliver qdots.  A common method 
used to deliver particles to the cytosol is via direct injection (9).  By directly 
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injecting NLS-functionalized particles into oocyte cytoplasm, it has been 
shown that they localize to the nucleus (23).  Electroporation has also been 
used to temporarily destabilize cellular membranes and deliver qdots (24). 
 In part 2 of the experimental results of this paper are described flexible 
methods for encapsulating our biofunctionalized qdots within phospholipid 
vesicles (liposomes).  There exists a large database of basic biological and 
clinical research dealing with functional delivery through the use of liposomal 
carriers.  Hence, it should be beneficial to show the compatibility of our 
system with their physiology and suggest possible means of utilizing them for 
cellular delivery. 
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Part 1: Quantum Dot Phase Transfer and Functionalization with 
Biomolecular Monolayers.  
Experimental  
 Our L-histidine mediated biofunctionalization protocol involves three 
mains steps (Figure 1).  1) The first step involves the exchange of 
TOPO/OAm ligand on 1-qdot with L-histidine at the qdot surface (A).  1-Qdot 
is diluted to <5µM in chloroform or toluene.  An aqueous phase containing 
enough 3:1 methanol:water 100mM L-histidine and 1M KOH to constitute a 
3000 molar excess of L-histidine to qdot is introduced to the organic phase 
and the mixture is vortexed for 1 minute.  For example, a typical phase 
transfer involves diluting 200µL of 40µM 1-qdot into 3mL toluene, adding 
240µL L-histidine solution and vortexing.  This induces a ligand exchange 
and subsequent phase-transfer to aqueous media as a result of 2-qdot 
formation. After precipitating with acetone, centrifuging at 4000rpm for 5min 
and removing supernatant, the 2-qdots are redispersed in 10mM borate buffer.   
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 2) The second step involves the exchange of L-histidine from 2-qdot 
with a thiolated organic ligand, usually either dihydrolipoic acid (DHLA) (3-
qdot), or mercaptoundecyl tetra(ethylene glycol) (PEG) (4-qdot).  For 
synthesis of 3-qdot, a 6000x molar excess of α-lipoic acid is reduced to 
DHLA by exposure to an aqueous solution of tris-(2-carboxyethyl)phosphine 
(TCEP) at twice the concentration of α-lipoic acid and pH = 2.  DHLA is 
extracted with a 3x volume of chloroform followed by rotary evaporation.  
The 2-qdots are then exposed directly to the dried DHLA and continuously 
mixed at 50°C for 1hr.  The resulting 3-qdots are pelleted by methanol 
precipitation and centrifugation at 4000rpm for 5min.  Supernatant containing 
excess ligand is removed and the 'clean' 3-qdots are resuspended in dH2O or 
phosphate-buffered saline (PBS) solution, depending upon immediate 
application.  Other thiolated monolayer-forming ligands, such as PEG, are 
used with similar results.  Incubation with 6000x molar excess of reduced 
PEG while mixing at 50°C for 1hr results in 4-qdot.  As testament to particle 
multimodality, we have formed mixed monolayers by utilizing corresponding 
fractions of ligand during the incubation process.  For instance, by utilizing 
varying amounts of PEG, which has no charge, and DHLA, which is 
negatively charged, we can quantify surface monolayer composition as a 
function of electrophoretic mobility as well as zeta potential (see Figure 2). 
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 3) The third step involves the attachment of biomolecules to qdot 
surfaces.  We have most extensively used thiol-DNA sequences for our qdot 
functionalization but we have also shown that cysteine-terminal peptide 
sequences can be effectively bound.  Attachment of thiol-DNA first involves 
10min incubation of DNA in a molar equivalent of sodium borohydride to 
ensure all disulfides have been reduced to thiol groups.  The oligonucleotide 
sequences are then added to 3-qdot in a 10:1 DNA:qdot ratio.  The NaCl 
concentration is increased to 100mM in order to screen negative charge 
interactions, and the mixture is left to incubate overnight.  Cysteine-terminal 
peptide sequences, such as the 13mer Simian Virus 40 (SV-40) Large T-
antigen Nuclear Localization Signal (NLS), can also be attached directly to 3-
qdots.  1mg of the reduced, lyophilized peptide is dissolved in 1mL dH2O 
(0.71µM).  The peptide solution is added to 3-qdot in a 10:1 peptide:qdot 
ratio, and the NaCl concentration is increased to 100mM in order to screen 
negative charge interactions. 
 Alternatively, and important to the utility of our 2-qdots, we have found 
that thiol-containing biomolecules can be attached directly to 2-qdot surfaces 
through replacement of L-histidine.  For example, SV-40 NLS peptide added 
to 2-qdot stock and incubated at 50°C for 1hr results in particles with bound 
peptide.  Functionalized qdots are analyzed by gel electrophoresis, in which 
lower mobility compared to 3-qdot or 2-qdot corresponds to greater amount of 
biomolecule attachment.  Loss of electrophoretic mobility is likely due to a 
combination of lowered overall negative charge at particle surface and/or 
increased tendency of particles to interact with agarose gel matrix (see Figure 
3). 
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 Qdot concentrations were calculated based on UV-vis optical 
absorption measurements of the qdot first band edge absorption (1s-1s) 
intensity using qdot size dependent optical extinction coefficients (εqdot).  Qdot 
size was correlated to absorption wavelength using previously described 
calibration methods (25, 26, 27), which was then used to estimate qdot 
extinction coefficient (εqdot).  For instance, a CdSe qdot with band edge 
absorption of 555 nm corresponds to a core diameter of ∼3.17 nm, which in 
turn determines the εqdot = 1.86 x 105 cm-1M-1.  The final qdot concentration 
was then obtained using the Beer-Lambert relationship Abs = εbc; where ε is 
the estimated extinction coefficient (M-1cm-1), b is the path length, and c is 
concentration (1). 
 Qdot quantum yield (QY) was calculated based on comparison to a 
reference dye using standard methods (28), using the equation:  
QYqdot (%) = QYR(ABSR/ABSqdot)(PLqdot/PLR)(ηqdot2/ηR2) 
where QYR is the reference dye quantum yield (Rhodamine = 31%, 
Rhodamine 6G = 95%), ABSR and ABSqdot are the optical absorption at 
specific excitation for the reference dye and qdot samples, respectively, and 
ηR and ηqdot are the refractive index of the reference and qdot solvents, 
Figure 3: A) Reduced electrophoretic mobility of 2-qdots exposed to 10x SV-40 
NLS peptide compared to 2-qdot or 3-qdot suggests succesful functionalization. 
1% Agarose gel in 1x TBE buffer run at 70V, 200mA, 30min. 
His-qdot! DHLA-qdot!NLS-qdot!
(1) (2) (3) 
(+) 
(-) 
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respectively (1).  Using this equation to measure QY of 1-qdots and 2-qdots, 
we found a typical QY loss of 47% (see Figure 4). 
 
Surface ligand characterization involves the use of nuclear magnetic 
resonance (NMR) imaging and fourier-transform infrared (FTIR) imaging.  
NMR: Qdots were prepared for NMR by multiple acetone precipitations to 
remove free ligand from solution. After precipitation, 1-qdots were 
redispersed in CHCl3 and rotary evaporated to a dry film. The dry film was 
then redispersed in CDCl3.  Similarly, 2-qdots and 3-qdots were redispersed in 
dH2O, rotary evaporated to form a thin film, and then dissolved in D2O. 
Typical qdot concentrations during NMR analysis were between 70-140µM. 
FTIR: Qdot samples were first cleaned with acetone precipitation, were dried 
to a film under air, and were then formed into KBr pellets using a hydraulic 
pellet press. After pellet formation, samples were placed under vacuum for 
48h. Spectra averaged over 128 scans and baseline corrected (see Figure 5). 
 
 
 
 
 
 
Figure 4: Representative QY calculated from measurements taken on a batch of qdot before phase transfer 
(1-qdot), after phase transfer (2-qdot), and after DHLA exchange (3-qdot).  From Zylstra et. al. 2011. 
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Materials, Part 1 
Histidine phase transfer:  L-histidine (His, 2, >99%), chloroform (CHCl3, >99.8%), 
methanol (MeOH >99.8%), acetone (99.5%), potassium hydroxide (KOH >99%), sodium 
tetraborate (99.998%), were obtained from Sigma-Aldrich and used without further 
purification.  Deuterated chloroform (CDCl3, 99.8%) and deuterium oxide (D2O, 99.8%) were 
obtained from Cambridge Isotope Laboratories and used without further purification. 
Ligand Exchange: 11-Mercaptoundecyl-tetra(ethylene glycol) (PEG, 4, 95%), α-lipoic acid 
(>99%), sodium borohydrate (NaBH4 >96%) hydrochloric acid (HCl >99%).   
DNA Functionalization:  DNA sequences, including 3'-HS-TTT-TTT-TTT-TTT-TCT-GTC-
ACA-TCT-CTT-5' (HS-SYR-3) and 3'-TMR-AAG-AGA-TGT-GAC-AGA-AAA-AAA-
AAA-AAA-5' (TMR-SYR-6) were purchased from Integrated DNA Technologies and 
redissolved in dH2O to a concentration of 5mM. 
Peptide Functionalization:  Simian Virus 40 (SV-40) Large T-antigen Nuclear Localization 
Signal (NLS) peptide, H2N-C-G-G-G-P-K-K-K-R-K-V-E-D-COOH, was purchased from 
Anaspec and redissolved in dH2O to a concentration of 1g/L (7.1x10-4M). 
Instrumentation:  Qdot absorbance measurements were collected on a Varian Cary100 Bio 
UV-Vis spectrophotometer between 200 and 900nm.  Photoluminescence was characterized 
using a Fluoromax-4 photon counting spectrofluorometer (Horiba Jobin Yvon).  Zeta-
Potential measurements were performed on a Malvern Zetasizer Nano Series instrument using 
a Malvern folded U-shaped capillary cuvette.  Gel electrophoresis experiments were 
performed using a conventional gel electrophoresis box with a VWR voltage regulator.  
Fourier Transform Infrared (FTIR) Spectroscopy was performed on a Nicolet 860 
spectrophotometer equipped with a liquid N2 cooled MCT detector.  Ultrapure water (18.2 
MΩ) was provided from a Sartorius Stedim Arium 61316 reverse osmosis unit with Arium 
611DI polishing unit. 
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Discussion, Part 1 
 Our qdot L-histidine-mediated phase transfer is efficient, as ligand 
exchanges appear to involve entire molecular monolayers.  It is important that 
all ligand is replaced (ie. TOPO/OAm) in order to mitigate any hydrophobic 
interactions between qdot, solvent, and future functional ligands.  We have 
characterized this exchange from 1-qdot to 2-qdot and from 2-qdot to 3-qdot 
using NMR imaging and FTIR spectroscopy (see Figure 5).  NMR taken of 1-
qdot shows the 1-qdot 1H resonances at ≈0.88 and ≈1.26 ppm, which is 
consistent with the alkyl backbone of TOPO/OAm, namely methyl (1a) and 
methylene (1b) protons, respectively.  In addition, the 1c and 1d resonances 
are observed at ≈ 5.4 (not shown) and ≈2 ppm respectively.  2-Qdots show 
four new resonances; 2a, 2b, 2c, and 2d that are characteristic of L-histidine.  
There is a considerable decrease (>98%) in resonance intensity at ≈1.28 ppm 
(1b), indicating the exchange of practically all the initial TOPO/OAm.  We 
observe resonances at ≈3.00, and ≈3.80 corresponding to the 2b- and 2a-
proton positions of 2, and resonances at ≈6.97 (2c) and ≈7.67 ppm (2d) that 
corresponds to the protons from the imidazole ring, which show broadened 
and decreased resonance intensities compared to the neat compound.  We 
hypothesize both the amine and the imidazole ring to be participating in qdot 
coordination, whose increased steric environment and crowding lead to 
resonance broadening (1), (see Figure 5A). 
 Similarly, the 1-qdots show FTIR signatures consistent with their long 
alkyl chains and methyl termination, namely –CH2 and –CH3 stretching at 
2850cm-1 and 2920cm-1 respectively, and a typical hydrophobic fingerprint 
region lacking any carbonyl stretching.  The 3-qdots show FTIR signatures 
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consistent with greater CH2 stretching at 2850 cm-1, the emergence of a 
carboxylate stretch at 1700 cm-1, and a completely altered fingerprint region 
(see Figure 5B).  Taken together, these results show the highly effective 
ligand exchange of both OAm and TOPO. 
 
 Much of the utility of 2-qdot comes from its transient surface molecule 
binding characteristics.  As previously mentioned in the experimental section, 
ligand exchange can be achieved by simply incubating DHLA with 2-qdot to 
form 3-qdot, which is cleaned and further incubated in the presence of thiol-
DNA to produce DNA-qdot (see Figure 6A).  The modest decrease in gel 
mobility from 3-qdot to DNA-qdot is evidence of DNA attachment, as the 
relatively large oligonucleotide sequences appear to inhibit qdot gel migration.  
Within proper ranges of temperature and salinity, DNA strands in solution that 
contain a complementary nucleotide sequence to the DNA attached to the qdot 
surface will couple through elementary Watson-Crick base pairing. 
 Alternatively, we have shown that 2-qdot can be directly functionalized 
with biomolecules, such as thiol-DNA or cysteine-terminal peptides.  
Attaching functional biomolecules to 2-qdots may afford greater experimental 
control as well as a higher overall number of attached biomolecules, because 
L-histidine maintains much more transient binding properties compared to 
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DHLA.  The weaker chelation of the imidazole/amino groups of L-histidine to 
the semiconductive surface is unable to compete with the stronger, more 
permanent binding of thiolated moieties.  This property can be used to our 
advantage to 'sculpt' a surface using two or more functional biomolecules.  
Only electrostatic repulsive forces seem to limit surface binding when 
attaching directly to 2-qdots, and not competitive binding interactions. 
 Concerning electrostatic repulsive forces, it is likely that bound-DNA 
inhibits further DNA attachment, due to negative charge-charge interactions.  
By incubating reduced SYR-3 in different salt concentrations, higher [Na+] in 
solution leads to higher numbers of thiol-DNA attaching to qdot surfaces 
(salt-screening).  Because 3-qdot is held in solution due to negatively charged 
carboxylic acid groups, there is a threshold at which the [Na+] causes 
precipitation of 3-qdots and irreversible aggregation, usually between 100mM 
and 150mM.  Curiously, 2-qdot has shown to be temporarily stable in very 
high salt concentrations, even up to 3M and beyond, allowing for increased 
DNA attachment (Figure 5B, 1-6). 
  
 As was previously mentioned, the uptake of qdots will ultimately serve 
as a limiting factor in their efficacy.  We have been investigating the response 
3
-q
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o
t 
D
N
A
-3
-q
d
o
t 
A 1 2 3 4 5 6 B 
Figure 6: A: Agarose gel showing decreased electrophoretic mobility of DNA-3-qdot compared to 3-qdot. 2-
Qdot does not run in 1xTBE buffer. B: 2-Qdot samples treated to 20xDNA and increasing [Na+] show 
decreasing electrophoretic mobility, which corresponds to greater DNA attachment. [Na+]: 0mM=1, 
100mM=2, 200mM=3, 500mM=4, 1M=5, 3M=6. 1% Agarose gel, 1xTBE buffer, 1hr, 70V, 200mA. 
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of HeLa cells in real time to various qdot solutions using confocal 
microscopy.  We have found that 3-qdots do not readily penetrate 
uncompromised cellular membranes, although some may be taken up slowly 
by an endocytic mechanism (4).  We are currently working on functionalizing 
3-qdot with molecular agonists for receptor-mediated endocytosis.  We are 
also working on liposomal systems for controlled delivery of functionalized 
qdots.  These liposomal systems are described in the section that follows. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: A: 3-qdots delivered to HeLa cells at 100nM are detected along cell 
peripheries, but not within cytosol.  B: However, when [3-qdot] is increased to 10µM, 
qdot fluorescence is detected within cytosolic domains, though not the nucleus. 
A B 
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Part 2: Qdots and Liposome Synthesis 
Experimental 
 The containment of 3-qdot within liposomes as well as the modification 
of liposomal membranes for biological targeting purposes was investigated.  
Liposome synthesis was carried out by following two experimental protocols, 
Gentle Hydration (29) and Reverse-Phase Evaporation (30), which were 
modified accordingly to current standards and individual conditions.  Most 
investigation and imaging was done using modifications of Gentle Hydration. 
Gentle Hydration Protocol: (see Figure 6) 
 This technique produces large (5-50µm diameter) liposomes, or Giant 
Unilamellar Vesicles (GUV), which can be easily characterized by light or 
confocal microscopy.  Stock solutions of phospholipid (PL) are prepared by 
dissolving 7.5mg/mL of phosphatidylcholine (PC) and phosphatidylglycerol 
(PG) in separate vials containing 2:1(v) CHCl3:MeOH.  Anhydrous methanol 
stored over 3Å molecular sieves is used.  Within the nitrogen atmosphere 
provided by a glovebox, 72µL of the PC stock solution and 8µL of the PG 
stock solution are added to a clean, dry 10mL RBF (Figure 6A).  These stock 
solutions are sealed and stored at -20°C for further use.  The RBF is 
parafilmed, removed from the glovebox, and transferred to a rotary evaporator 
with water bath heated to 40°C.  The organic solvent is removed under 
reduced pressure while rotating the RBF (speed=2) in the water bath.  Ideally, 
a thin PL film will form across a 3-5cm2 area on the inside of the RBF (Figure 
6B).  After the organic solvent is visibly removed, the film is left under 
vacuum for at least 6hr to remove traces of solvent.  The film is briefly cooled 
by evaporating acetone on the outside of the RBF, and then 5mL of ice-cold 
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0.1M sucrose solution is gently placed over the film using a 10mL pipette 
(Figure 6C).  The mixture is incubated overnight in a magnetically stirred 
water (or oil) bath heated to 40°C.  The film lifts off from the glass over a 
period of minutes to hours (Figure 6D) and eventually forms a translucent 
spheroid floating within the aqueous media (Figure 7).  This spheroid is 
harvested using a glass pipette and stored in isotonic solution.  For imaging or 
characterization, it is redispersed and diluted in isotonic solution. 
 
Reverse-Phase Evaporation Protocol: 
 This technique produces liposomes of a much smaller average diameter 
and is also significantly less time-consuming.  It involves first dissolving 
20µmol PG, 80µmol PC, and 100µmol cholesterol in organic media 
consisting of 3mL diethyl ether and 3mL chloroform.  These amounts can be 
scaled up or down, so long as all ratios remain the same.  1mL of 1/10 dilution 
Phosphate-buffered saline (PBS) is added directly to this organic media in a 
10mL roundbottom flask.  The two-phase mixture is sonicated at 5°C for 
20min, until it forms an opaque emulsion.  This emulsion is rotated at 25°C 
under pressure reduced enough so that a controlled frothing is visible.  When 
all that remains is an opaque solid material, the pressure is returned to 
Figure 6: Gentle Hydration synthetic protocol. Net neutral charge phosphatidylcholine (PC) and net negative charge 
phosphatidylglycerol (PG) constitute liposomal membranes. A: 10:1 PC:PG is dissolved in a 1:1(v) chloroform : methanol 
organic phase in a 10mL RBF.  1: The organic solvent is evaporated under reduced pressure at 40°C and kept under 
vacuum >6hr.  B: PL remain as a film of stacked bilayers.  C: The film is carefully hydrated with cold 0.1M sucrose.  2:  
The aquated film is incubated at 37°C overnight, resulting in D: the liposomal stock solution. 
A B C D 
1 2 
organic solution PL film hydration 
PC PG 
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atmospheric and the temperature is increased to 40°C.  After 15-30min of 
further rotation/incubation, the material becomes a gelatinous spheroid, which 
is stored in aqueous solution (Figure 7).  As with gentle hydration, the 
liposomal mass is diluted in isotonic solution for imaging or characterization. 
 
Materials, Part 2 
Gentle Hydration: Chicken egg-derived L-α-phosphatidylcholine (PC, 99%), and chicken 
egg-derived L-α-phosphatidylglycerol (PG, 99%) were purchased from Avanti Polar Lipids. 
Chloroform (CHCl3, >99.8%), and dry methanol (MeOH >99.8%) were obtained from Sigma 
Aldrich and used without further purification.  Rhodamine 6G and Cresyl Violet dyes were 
obtained from Sigma Aldrich and were diluted to 10mM in chloroform and methanol, 
respectively. 
Reverse-Phase Evaporation: Chicken egg-derived L-α-phosphatidylcholine (PC, 99%), 
chicken egg-derived L-α-phosphatidylglycerol (PG, 99%), and ovine wool-derived 
cholesterol (99%) were purchased from Avanti Polar Lipids. Chloroform (CHCl3, >99.8%), 
and methanol (MeOH >99.8%) were obtained from Sigma Aldrich and used without further 
purification. 
Instrumentation:  Zeiss Axio 710 confocal microscope used to image liposomes, a Vacuum 
Atmospheres Omni glovebox was used to prepare liposome precursor mixtures from stock 
solutions under nitrogen atmospheric conditions, Thermo Scientific Cimarec heating plate 
was used for incubating samples, an Edwards RV3 vacuum pump and Buchi RII Rotary 
Evaporator were used for removing nonpolar solvents and drying samples, Malvern 
Instruments Zetasizer Nano Series used for DLS measurements. 
 
A B C D E 
Figure 7: Appearance of liposomal spheroids after ‘Gentle Hydration’ in a number of experimental conditions.  
A: Basic Conditions, B: 3-Qdot hydration, C: Rhodamine 6G labeling, D: Cresyl Violet labeling, E: 1-Qdot 
labeling, F: Reverse-Phase Evaporation method.  Spheroid positions indicated by red arrows. 
F 
  18 
Results and Discussion, Part 2 
 A number of experiments were carried out to explore the encapsulation 
properties of liposomes formed via the hydration of lipid films.  A control 
experiment was initially designed in which only the minimal reagents were 
used to produce liposomes.  These were imaged via confocal microscopy 
(Figure 8A).  Many spherical, transparent structures were observed, though 
with little readily observed detail concerning the existence of higher-order 
structures.  The ideal imaging concentration involved dilution of the original 
spheroid volume 10 times its original value. 
 After successfully synthesizing a control batch, the first liposome 
experiment involved determining whether it would be possible to encapsulate 
aqueous 3-qdot within the internal space of the liposomes (see Figure 8B).  A 
phospholipid film was prepared under normal conditions.  It was then 
hydrated using a 0.1M sucrose solution containing 5µM 3-qdot.  The resulting 
liposomes were harvested, redispersed, and diluted to 1/10th concentration.  
They were imaged via confocal microscopy and illuminated under both white 
light and a 405nm laser to induce fluorescence of internalized 3-qdot.  
Liposomes were observed of similar morphology to the control batch.  Most 
of the liposomes contained a fluorescent 3-qdot 'cloud' within their internal 
space that seemed to maintain itself toward the center of the liposome and 
away from the membrane.  It is possible that this occurs because both the 
membrane and 3-qdot are negatively charged, disfavoring contact between 
them.  The results of this experiment strongly indicated that these liposomes 
can efficiently encapsulate negatively charged qdots and also suggested that 
these liposomes to be able to carry other negatively-charged nanoparticles. 
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 In Figure 8 above, it is often difficult to distinguish the boundaries 
defined by the liposomal membranes.  In response to this, an experiment was 
designed in which rhodamine 6G, an organic dye with exceptionally high 
quantum yield (see Figure 9), was introduced to the lipid/chloroform/methanol 
solution and dried into the phospholipid film.  Rhodamine 6G, an esterified 
form of rhodamine, is hydrophobic and has a broad emission spectrum 
peaking at 550nm.  The hypothesis for this experiment was that the 
fluorescent dye would remain solubilized in the hydrophobic region between 
bilayer leaflets, providing a means to clearly image the liposomal membrane.   
 
A 
Figure 8: A: GUV synthesized according to the Gentle Hydration protocol show highly 
spherical morphology under confocal microscopy. B: GUV synthesized in a hydrating media 
containing 3-qdot show internalized 3-qdot cloud-like structures.  Scale bar represents 25µm 
3-Qdots 
GUV 
25µm 
B 
membrane 
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 When the phospholipid film was hydrated, the resulting liposomal 
spheroid appeared to contain all of the dye (see Figure 7).  After harvesting 
and diluting the liposomes, they were imaged under confocal microscopy.  
These pictures provided a very clear view of all liposomal membranes.  Many 
of the liposomes appeared to consist of a large sphere maintained by a single 
membrane.  However, a significant population consisted of more complex 
morphologies, such as concentric membrane layers, liposomes-in-liposomes, 
and tube-like structures (Figure 10). 
 Another organic dye, cresyl violet (see Figure 9), was used in a similar 
manner to rhodamine 6G.  Cresyl violet has a broad emission spectrum, with a 
fluorescence peak at 620nm.  The differences in the emission spectra of cresyl 
violet and rhodamine 6G could possibly be used to differentiate vesicles made 
from different stocks that are mixed together and imaged under confocal 
microscopy.  However, the efficacy of this hypothesis was not well 
A B 
Figure 10: A: Rhodamine 6G labeling of all liposomal membranes reveals the presence of GUVs (i), 
liposomes-in-liposomes (ii), concentric bilayers (iii), tube-like structures (iv), and combinations of these 
(iv, v). B: Cresyl violet labeling of membranes did not provide high resolution imaging compared to 
rhodamine 6G. Images via Zeiss Axio 710 confocal microscope.  Scale bar represents 25µm. 
ii 
i 
iii 
iv 
v 
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investigated.  Cresyl violet has a lower quantum yield compared to rhodamine 
6G (54% compared to 95%) and so it is not as efficient an imaging agent.  
Also, cresyl violet is methanol (and not chloroform/methanol) soluble, and so 
the film was made with methanol only.  Still, cresyl violet functioned as a 
membrane-intercalating label (Figure 10). 
 Due to the ease by which hydrophobic dyes could be incorporated 
within liposomal lipid bilayers, we began to consider the possibility of 
inserting other, more ambitious entities.  With the concept of integral 
membrane proteins in mind, it was hypothesized that 1-qdots could be bound 
similarly within membrane bilayers.  Unmodified 1-qdot was added to the 
organic lipid solution (Figure 6A) in a 10,000:1, PL:qdot ratio (31).  This was 
dried to a film in which QD fluorescence was evenly distributed.  It was found 
that the organic lipid solution could consist of only trace amounts of methanol 
for 1-qdot distribution to evenly occur within the film.  After overnight 
vacuum, the film was hydrated using 0.1M sucrose at 40°C.  It took 
significantly longer to hydrate this film, which had been initially dissolved in 
only chloroform, and not chloroform/methanol.  The resulting spheroid 
liposomal mass was diluted and imaged using confocal microscopy.  
Membrane-associated fluorescence was observed, though only at an increased 
laser power and scanning gain (see Figure 11). 
 The resulting liposomes that had been synthesized from a film 
containing 1-qdot showed weak fluorescence corresponding to ~550nm.  This 
demonstrated that there were 1-qdots maintained between membrane bilayers.  
However, fluorescence was observed almost exclusively in regions of high 
multilamellarity (Figure 11, i, ii, iii) or within alternative lipid polymorphic 
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structures (Figure 11, vii, viii, ix).  While some liposomes were observed to 
contain a fluorescent barrier surrounding a large internal aqueous space 
(Figure 11, iv, v, vi), the unilamellarity of these vesicles is not clear.   
 Relative to previous experiments, it appeared under confocal analysis 
that there were higher numbers of multilamellar and alternative lipid 
structures.  It is hypothesized that this was not due to the incorporation of 1-
qdot, but rather the lack of methanol used during film formation, due to its 
precipitating effect on 1-qdot.  It is likely that methanol plays an important 
role in positioning phospholipids during film formation so as to facilitate 
efficient hydration and separation between bilayers.  It may be beneficial to 
investigate alternative solvents with moderate hydrophilicity to replace 
methanol, such as diethyl ether or ethyl acetate, in future experiments. 
 
 
D 
Figure 9: GUV containing membrane-bound 1-qdot showing very high multilamellarity (i, ii, iii), 
though some structures present relatively large aqueous regions (iv, v, vi).  1-Qdot appears to have 
high affinity for multilamellar regions (i, ii, iii, vii) and tube-like morphologies (viii, ix).  Imaged 
via Zeiss Axio 710 confocal microscope.  Scale bars represent 25µm. 
i 
ii 
iii 
iv 
v 
vi 
vii 
viii 
ix 
    23 
Conclusions 
 We have shown that qdots synthesized under hydrophobic conditions (1-
qdots) can be effectively phase-transferred via ligand exchange with the 
amino acid L-histidine.  The amino acid efficiently displaces TOPO/OAm 
from the qdot surface and maintains particles with an acceptable quantum 
yield.  Furthermore, the bidentate, nitrogenous chelation of L-histidine 
exhibits enough binding strength to maintain 2-qdots in Tris, Borate, or 
Phosphate, buffers, even under saline conditions.  Importantly, L-histidine 
does not compete with stronger binding thiol groups, allowing its use as an 
intermediate functionality. That is, thiolated molecules exposed to 2-qdots 
will permanently displace L-histidine from qdot surfaces to form monolayers.  
We have shown that this applies to ratios of molecules, such as DHLA/PEG.  
We have also shown that it provides an ideal platform for the attachment of 
larger, functional biomolecules, such as cysteine-terminal peptides and 
thiolated DNA. 
 Furthermore, the versatility of liposome preparation techniques 
involving the hydration of negatively-charged lipid bilayers dried to a film 
was demonstrated through a number of investigations and subsequent 
characterization under confocal microscopy.  We showed these liposomes to 
be very efficient at internalizing negatively-charged aqueous qdots present in 
the hydrating media.  We also illustrated the utility of fluorescent, 
hydrophobic dyes, most importantly Rhodamine 6G, for labeling all liposomal 
membranes and elucidating liposomal polymorphism.  Finally, we have 
shown that some hydrophobic qdots will remain bound within liposomal 
membranes if present within phospholipid film. 
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 Future direction concerning this topic would be directed at means of 
reproducibly delivering liposome-encapsulated, functionalized qdots to 
cytoplasmic domains.  If liposomes can be induced to fuse with cellular 
membranes and not endocytosed/phagocytosed, biofunctional qdots will have 
access to crucial intracellular machinery, allowing for their subcellular 
organelle trafficking and localization.  This property might be induced via 
functionalization of the liposomal membrane itself, either through the use of 
membrane-bound particles or the incorporation of amphipathic, chemical 
moieties.  In any case, there is much room here for further biological 
investigation.  
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Project General Summary 
Introduction 
 Quantum dots (qdots) are nanometer-scale crystalline particles that 
consist of an inorganic semiconductive core material and a bound outer 
molecular coating.  The semiconductive core of qdots is responsible for their 
characteristic property: fluorescence.  Our qdots absorb ultraviolet radiation 
and release visible light, the wavelength of which can be altered depending 
upon the size of synthesized semiconductive cores.  For instance, when our 
qdots are synthesized with a 2.5nm core diameter, they will fluoresce at a 
wavelength of ~500nm, corresponding to green light.  Larger particles 
fluoresce at higher wavelengths, corresponding to emission spectra shifted 
toward red.  Qdots are maintained within liquid solutions because of the 
presence of a bound outer molecular coating.  Indeed, defects in this coating 
or an unstable coating result in qdots aggregating and precipitating from 
solution, often permanently.  Furthermore, the identity of bound surface 
molecules crucially determines the solubility properties of the particles 
themselves.  For instance, when qdots are synthesized, they contain a bound 
surface layer of trioctylphosphine oxide (TOPO) and oleylamine (OAm), both 
hydrophobic ligands, and are soluble within hydrophobic solvents such as 
chloroform, hexane, or toluene. 
 
Phase Transfer, Ligand Exchange, and Biomolecule Attachment 
 The systems in which we are working are biological and hence, 
aqueous.  To make our particles compatible with these systems and soluble in 
aqueous solutions, it is necessary to manipulate the molecular surface profile 
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so that it presents hydrophilic molecules to the solvent.  We have tuned a 
method for quickly and efficiently swapping the initial hydrophobic 
TOPO/OAm surface layer with L-histidine, a natural amino acid, which 
presents hydrophilic carboxylic acid groups to the surrounding solvent and 
subsequently leads to the phase-transfer of particles from the organic solvent 
to the aqueous solvent.  Furthermore, while L-histidine readily displaces 
TOPO/OAm under certain conditions, it maintains transient binding properties 
to the qdot surface.  Due to this facile attachment/detachment property, we 
have been using L-histidine coated qdots for the permanent attachment of a 
range of other aqueous molecules to qdot surfaces.  For instance, we use 
dihydrolipoic acid (DHLA), thiolated polyethylene glycol (PEG), or mixtures 
of the two to displace L-histidine and produce a strongly-bound and 
biologically compatible molecular surface.    
 While DHLA and PEG provide biological compatibility, they only 
maintain non-specific solvent interactions.  Biological molecules such as 
DNA or peptide sequences are attached to provide more specific, targeted 
interactions.  DNA sequences are used as attachment sites for complementary 
strands.  That is, within proper ranges of temperature and salinity (mimicking 
physiological conditions), DNA strands in solution that contain a 
complementary nucleotide sequence to the DNA attached to the qdot surface 
will couple with each other through elementary watson-crick base pairing.  
Similarly, certain peptide sequences have specific cellular binding partners 
that are used to target qdots to desired areas.  For instance, Simian Virus 40 
contains a short peptide sequence that is known to bind to a cellular chaperone 
protein, importin α, which takes the virus to the nucleus.  Qdots containing 
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this peptide bound to their surface are shuttled to the nucleus by importin α, 
whereas those that lack it will remain within the cytoplasm. 
 
Qdot Characterization 
 Qdot concentrations and sizes are measured using UV-Visible 
spectroscopy, which gives us data concerning qdot light absorbance.  
Information concerning qdot fluorescence intensity and frequency are 
obtained via fluorescence spectroscopy.  Quantum yield, which is a measure 
of the efficiency at which fluorophores (qdots) are able to convert absorbed 
light into emitted light, is calculated using a combination of UV-Vis and 
fluorescence spectroscopy. 
 Agarose gel electrophoresis is used to provide data concerning the net 
charge of qdot-bound surface ligands as well as the number of bulky bound 
surface molecules, such as DNA.  These factors correlate to electrophoretic 
mobility, the rate at which particles migrate within a gel in response to an 
applied electric current.  More negatively charged particles migrate faster 
within a gel, whereas particles with attached bulky biomolecules tend to lose 
mobility as a function of the amount bound to the surface.  We obtain specific 
information affirming the identity of qdot bound surface molecules using both 
Fourier Transform Infra-Red (FTIR) and Nuclear Magnetic Resonance 
(NMR) imaging.  Qdot cores do not significantly alter NMR or IR absorbance 
patterns of attached ligands compared to their free state.  Hence, we are able 
to utilize existing structural analysis of data to confirm qdot ligand profile. 
 Finally, we are using confocal microscopy to observe and image the 
interaction between qdots and biological systems.  Qdot fluorescence allows 
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us to track the response of HeLa cells in real time to qdots with various bound 
surface molecules.  Confocal microscopy is also used in the characterization 
of liposomes, further described below. 
  
Liposomal Encapsulation for Cellular Delivery 
 The uptake of qdots will ultimately serve as a limiting factor in their 
efficacy.  One method by which qdots could be packaged and delivered to 
cells is through the use of liposomes.  Liposomes consist of a membrane made 
of phospholipids, cholesterol, and/or other amphipathic components that 
encapsulates its surrounding solution during synthesis.  The diameters of 
liposomes span an enormous possible range, from >100µm to <100nm, 
depending upon their method of synthesis as well as post-synthetic 
processing.  Liposomal membranes maintain permeability only to small or 
highly bioavailable molecules, similar to cellular membranes.  This property 
allows their efficient encapsulation of, among other things, aqueous qdots.  
 We have synthesized liposomes by forming and hydrating a film of 
phospholipid bilayers, which subsequently encapsulate the solution 
components in which they are formed.  We use both phosphatidylcholine (PC) 
and phosphatidylglycerol (PG), which give the membrane a negative charge 
proportional to the fraction of PG used.  The phospholipid film is first formed 
by dissolving phospholipids in an organic solution and then evaporating the 
organic solvent, leaving behind a thin phospholipid residue.  When all of the 
organic solvent has been removed, the film is placed in an aqueous solution 
containing desired 'cargo' molecules and incubated at 40°C until the film lifts 
off the glass and forms a spherical structure floating in solution containing 
  30 
liposomes.  This spheroid is removed from the incubating solution and 
redispersed in isotonic media where it forms a liposomal stock solution. 
 We have shown that when an aqueous solution containing 3-qdots is 
used for liposomal hydration, the liposomes subsequently contain 
encapsulated 3-qdot that does not appear to diffuse across the membrane.  
Interestingly, the encapsulated 3-qdots appear to maintain themselves most 
favorably as a 'cloud' that stays an appreciable distance from the negatively 
charged membrane.  We've also shown that fluorescent hydrophobic dyes, 
such as Rhodamine 6G and Cresyl Violet, will remain only between the 
liposomal membrane bilayers, and not in the internal aqueous space if the 
phospholipid film is formed in the presence of those dyes.  Hence, rhodamine 
6G is used as an efficient membrane label during imaging.  Furthermore, we 
have shown that hydrophobic qdots, such as 1-qdot, can be similarly used 
during film formation and remain embedded within the membrane after 
liposome formation.  
  
Liposomal Characterization 
 Liposomes are imaged under confocal microscopy, which allows 
determination of successful encapsulation.  The software associated with the 
Zeiss 710 microscope we are using also allows characterization of other 
liposomal properties, such as diameter.  We also use dynamic light scattering 
(DLS) as a method to determine overall liposomal population diameters, 
which we tend to be much smaller than those liposomes visible under confocal 
microscopy.  Liposomes can be purified by column chromatography, and 
diameters can be decreased and homogenized using polycarbonate filters. 
